Accustem Sciences Inc. SEC filings ACUT
Accustem Sciences Inc. has 76 filings in SEC EDGAR's recent list, going back to Mar 12, 2021. Its latest annual report, Form 10-K, was filed on Apr 14, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 26, 2025 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Apr 14, 2026 | Dec 31, 2025 |
| NT 10-K | Filing | Mar 31, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Other events
|
Nov 26, 2025 | Nov 26, 2025 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 13, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 10-Q | Quarterly report | May 20, 2025 | Mar 31, 2025 |
| NT 10-Q | Filing | May 15, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 10, 2025 | Apr 8, 2025 |
| 4 | Insider transaction | Apr 8, 2025 | Mar 18, 2025 |
| 10-K | Annual report | Apr 3, 2025 | Dec 31, 2024 |
| NT 10-K | Filing | Mar 31, 2025 | Dec 31, 2024 |
| SEC STAFF ACTION | Filing | Feb 21, 2025 | — |
| 4 | Insider transaction | Jan 3, 2025 | Dec 31, 2024 |
| 8-K/A |
Amended current report
Auditor change
|
Jan 2, 2025 | Jun 17, 2024 |
| 8-K |
Current report
Auditor change
|
Dec 30, 2024 | Jun 17, 2024 |
| 10-Q | Quarterly report | Nov 18, 2024 | Sep 30, 2024 |
| NT 10-Q | Filing | Nov 14, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Sep 16, 2024 | Jun 30, 2024 |
| NT 10-Q | Filing | Aug 14, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | May 20, 2024 | Mar 31, 2024 |
| NT 10-Q | Filing | May 15, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Auditor change
|
Apr 10, 2024 | Apr 4, 2024 |
| 10-K | Annual report | Mar 22, 2024 | Dec 31, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Officer or director change
|
Jun 9, 2023 | Jun 5, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 7, 2023 | Jun 6, 2023 |
| 10-Q | Quarterly report | May 5, 2023 | Mar 31, 2023 |
| 10-K/A | Amended annual report | Apr 28, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Feb 15, 2023 | Dec 31, 2022 |
| S-1/A | Amended registration statement | Jan 19, 2023 | — |
| 4 | Insider transaction | Jan 3, 2023 | Dec 30, 2022 |
| 4 | Insider transaction | Dec 5, 2022 | Dec 2, 2022 |
| 4 | Insider transaction | Nov 22, 2022 | Nov 18, 2022 |
| S-1 | Registration statement | Nov 17, 2022 | — |
| 8-K |
Current report
Officer or director change
|
Nov 16, 2022 | Nov 14, 2022 |
| 10-Q | Quarterly report | Nov 8, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Oct 14, 2022 | Oct 14, 2022 |
| DEFA14A | Additional proxy material | Oct 11, 2022 | — |
| DEF 14A | Proxy statement | Sep 14, 2022 | Sep 14, 2022 |
| PRE 14A | Preliminary proxy statement | Sep 2, 2022 | Sep 2, 2022 |
| 10-Q | Quarterly report | Aug 12, 2022 | Jun 30, 2022 |
| 4 | Insider transaction | Aug 2, 2022 | Aug 1, 2022 |
| DRS | Filing | Jul 29, 2022 | — |
| 8-K |
Current report
Officer or director change
|
Jun 21, 2022 | Jun 20, 2022 |
| 4 | Insider transaction | Jun 9, 2022 | Jun 8, 2022 |
| 3 | Initial insider ownership | May 27, 2022 | Dec 1, 2021 |
| 3 | Initial insider ownership | May 27, 2022 | Mar 4, 2022 |
| 3 | Initial insider ownership | May 27, 2022 | Dec 1, 2021 |
| 10-Q | Quarterly report | May 20, 2022 | Mar 31, 2022 |
| NT 10-Q | Filing | May 17, 2022 | Mar 31, 2022 |
| 4 | Insider transaction | Apr 27, 2022 | Apr 25, 2022 |
| 10-K | Annual report | Apr 18, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change
|
Apr 5, 2022 | Mar 30, 2022 |
| NT 10-K | Filing | Mar 31, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 10, 2022 | Mar 4, 2022 |
| 3 | Initial insider ownership | Jan 14, 2022 | Dec 2, 2021 |
| 3 | Initial insider ownership | Dec 9, 2021 | Dec 1, 2021 |
| 3 | Initial insider ownership | Dec 3, 2021 | Dec 1, 2021 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Other events
|
Dec 3, 2021 | Dec 1, 2021 |
| EFFECT | Filing | Jul 1, 2021 | — |
| SEC STAFF ACTION | Filing | Jul 1, 2021 | — |
| F-6 | Registration statement | Jun 23, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 7, 2021 | — |
| 20FR12G/A | Filing | Jun 1, 2021 | — |
| CORRESP | Letter to the SEC | May 28, 2021 | — |
| UPLOAD | Letter from the SEC | May 14, 2021 | — |
| 20FR12G/A | Filing | May 7, 2021 | — |
| CORRESP | Letter to the SEC | May 6, 2021 | — |
| UPLOAD | Letter from the SEC | May 3, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 8, 2021 | — |
| 20FR12G | Filing | Mar 12, 2021 | — |
Showing 76 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ACUT (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1850767
- Former names
- AccuStem Sciences Ltd (until Jul 1, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.